183 related articles for article (PubMed ID: 16945113)
1. Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin.
León J; Escames G; Rodríguez MI; López LC; Tapias V; Entrena A; Camacho E; Carrión MD; Gallo MA; Espinosa A; Tan DX; Reiter RJ; Acuña-Castroviejo D
J Neurochem; 2006 Sep; 98(6):2023-33. PubMed ID: 16945113
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.
Mayo JC; Sainz RM; Tan DX; Hardeland R; Leon J; Rodriguez C; Reiter RJ
J Neuroimmunol; 2005 Aug; 165(1-2):139-49. PubMed ID: 15975667
[TBL] [Abstract][Full Text] [Related]
3. Oxidation of melatonin and its catabolites, N1-acetyl-N2 -formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine, by activated leukocytes.
Silva SO; Rodrigues MR; Carvalho SR; Catalani LH; Campa A; Ximenes VF
J Pineal Res; 2004 Oct; 37(3):171-5. PubMed ID: 15357661
[TBL] [Abstract][Full Text] [Related]
4. The melatonin metabolite N1-acetyl-5-methoxykynuramine facilitates long-term object memory in young and aging mice.
Iwashita H; Matsumoto Y; Maruyama Y; Watanabe K; Chiba A; Hattori A
J Pineal Res; 2021 Jan; 70(1):e12703. PubMed ID: 33125735
[TBL] [Abstract][Full Text] [Related]
5. Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice.
Tapias V; Escames G; López LC; López A; Camacho E; Carrión MD; Entrena A; Gallo MA; Espinosa A; Acuña-Castroviejo D
J Neurosci Res; 2009 Oct; 87(13):3002-10. PubMed ID: 19437546
[TBL] [Abstract][Full Text] [Related]
6. Analysis of N1-acetyl-N2-formyl-5-methoxykynuramine/N1-acetyl-5-methoxy-kynuramine formation from melatonin in mice.
Niu S; Li F; Tan DX; Zhang L; Idle JR; Gonzalez FJ; Ma X
J Pineal Res; 2010 Sep; 49(2):106-14. PubMed ID: 20545825
[TBL] [Abstract][Full Text] [Related]
7. N1-Acetyl-5-methoxykynuramine, which decreases in the hippocampus with aging, improves long-term memory via CaMKII/CREB phosphorylation.
Watanabe K; Maruyama Y; Iwashita H; Kato H; Hirayama J; Hattori A
J Pineal Res; 2024 Jan; 76(1):e12934. PubMed ID: 38241676
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction.
Ressmeyer AR; Mayo JC; Zelosko V; Sáinz RM; Tan DX; Poeggeler B; Antolín I; Zsizsik BK; Reiter RJ; Hardeland R
Redox Rep; 2003; 8(4):205-13. PubMed ID: 14599344
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoassay of N-acetyl-N-formyl-5-methoxykynuramine (AFMK): a melatonin oxidative metabolite.
Harthé C; Claudy D; Déchaud H; Vivien-Roels B; Pévet P; Claustrat B
Life Sci; 2003 Aug; 73(12):1587-97. PubMed ID: 12865098
[TBL] [Abstract][Full Text] [Related]
10. Kynurenamines as neural nitric oxide synthase inhibitors.
Entrena A; Camacho ME; Carrión MD; López-Cara LC; Velasco G; León J; Escames G; Acuña-Castroviejo D; Tapias V; Gallo MA; Vivó A; Espinosa A
J Med Chem; 2005 Dec; 48(26):8174-81. PubMed ID: 16366599
[TBL] [Abstract][Full Text] [Related]
11. Structure-related inhibition of calmodulin-dependent neuronal nitric-oxide synthase activity by melatonin and synthetic kynurenines.
León J; Macías M; Escames G; Camacho E; Khaldy H; Martín M; Espinosa A; Gallo MA; Acuña-Castroviejo D
Mol Pharmacol; 2000 Nov; 58(5):967-75. PubMed ID: 11040043
[TBL] [Abstract][Full Text] [Related]
12. Novel pathway for N1-acetyl-5-methoxykynuramine: UVB-induced liberation of carbon monoxide from precursor N1-acetyl-N2-formyl-5-methoxykynuramine.
Seever K; Hardeland R
J Pineal Res; 2008 May; 44(4):450-5. PubMed ID: 18194200
[TBL] [Abstract][Full Text] [Related]
13. Reactions of the melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK.
Guenther AL; Schmidt SI; Laatsch H; Fotso S; Ness H; Ressmeyer AR; Poeggeler B; Hardeland R
J Pineal Res; 2005 Oct; 39(3):251-60. PubMed ID: 16150105
[TBL] [Abstract][Full Text] [Related]
14. The melatonin metabolite N-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger.
Schaefer M; Hardeland R
J Pineal Res; 2009 Jan; 46(1):49-52. PubMed ID: 18643875
[TBL] [Abstract][Full Text] [Related]
15. N1-Acetyl-5-Methoxykynuramine (AMK) is produced in the human epidermis and shows antiproliferative effects.
Kim TK; Lin Z; Li W; Reiter RJ; Slominski AT
Endocrinology; 2015 May; 156(5):1630-6. PubMed ID: 25679869
[TBL] [Abstract][Full Text] [Related]
16. Melatonin and its kynurenin-like oxidation products affect the microbicidal activity of neutrophils.
Silva SO; Carvalho SR; Ximenes VF; Okada SS; Campa A
Microbes Infect; 2006 Feb; 8(2):420-5. PubMed ID: 16242372
[TBL] [Abstract][Full Text] [Related]
17. Reactions of the NO redox forms NO+, *NO and HNO (protonated NO-) with the melatonin metabolite N1-acetyl-5-methoxykynuramine.
Hardeland R; Backhaus C; Fadavi A
J Pineal Res; 2007 Nov; 43(4):382-8. PubMed ID: 17910607
[TBL] [Abstract][Full Text] [Related]
18. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK.
Galano A; Tan DX; Reiter RJ
J Pineal Res; 2013 Apr; 54(3):245-57. PubMed ID: 22998574
[TBL] [Abstract][Full Text] [Related]
19. N1-acetyl-N2-formyl-5-methoxykynuramine is a product of melatonin oxidation in rats.
Rozov SV; Filatova EV; Orlov AA; Volkova AV; Zhloba AR; Blashko EL; Pozdeyev NV
J Pineal Res; 2003 Nov; 35(4):245-50. PubMed ID: 14521629
[TBL] [Abstract][Full Text] [Related]
20. Reactions of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK) with the tyrosine side-chain fragment, 4-ethylphenol.
Nowak A; Rahman H; Heer C; Schueth A; Laatsch H; Hardeland R
Redox Rep; 2008; 13(3):102-8. PubMed ID: 18544227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
